NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Judo Bio

Judo Bio

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://judo.bio/

Last Round

Series A

Oct 7, 2024

Total Funding Raised

$100M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Judo Bio is a biotechnology company that develops oligonucleotide therapies for systemic and renal diseases by pairing gene-silencing nucleic acids with targeting molecules for specific kidney cells.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

oligonucleotide therapygene silencingkidney diseasedrug delivery platformRNA therapeuticssiRNAtargeted drug deliverybiotech startupreceptor-mediated deliverydrug discoveryligand-siRNA conjugatepreclinical developmentrenal therapeutics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Judo Bio Comparables

Compare Judo Bio with similar companies based on industry and business-model similarity.

Judo Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Borealis Biosciences
91%
Hybridize Therapeutics
82%
Rigerna Therapeutics
79%

Judo Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AOct 7, 2024
SeedOct 7, 2024

Key People

Founding team and executive leadership

Rajiv Patni

Chief Executive Officer

Executive Team

Judo Bio Investors

Notable investors and investment history

Judo Bio investors
InvestorRounds
The Column GroupSeries A, Seed
Digitalis VenturesSeries A
YK BioventuresSeries A
Droia VenturesSeries A
The Chernin GroupSeries A, Seed
The Chatterjee GroupSeries A
Alexandria Venture InvestmentsSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 16, 2026

    Monthly visitors increased 38% MoM.

  • Oct 7, 2024

    Led by The Chernin Group and Atlas Venture.

Judo Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Judo Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Judo Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range32
Year Founded2021
Last FundingOct 7, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.